Journal of Allergy and Clinical Immunology-In Practice

Papers
(The H4-Index of Journal of Allergy and Clinical Immunology-In Practice is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Table of Contents170
Practice Notes from the AAAI164
Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use137
Information for Readers127
March 2023 Practice Notes110
Managing Atopic Dermatitis in Patients With Skin of Color107
CME exam: Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity105
CME exam: Take a Leap of Faith: Implement Routine Genetic Testing in Your Office94
Scratching the Itch: Managing Recurrent Pruritic Skin Conditions89
CME Exam: Long-Term Respiratory Consequences of Early-Life Respiratory Viral Infections: A Pragmatic Approach to Fundamental Questions87
Original Article Highlights From This Issue85
COVID-19 Treatments: Then and Now80
Keeping Our Eyes on the Prize: Personalized and Precision Medicine With Biologics for Chronic Rhinosinusitis With Nasal Polyps77
Ask Not What AI Can Do to Us, but What We Can Do with AI74
Two-step nonsteroidal anti-inflammatory drug challenges during pregnancy: A case series73
Resolution of hypereosinophilic syndrome following resection of a schwannoma70
Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 8070
Giant Papillary Conjunctivitis Caused by a Fibroepithelial Polyp of the Lower Eyelid69
Adherence Challenges and Strategies in Specific Groups With Asthma: Adolescents, Pregnancy, and Older Adults67
Once- or Twice-Daily Inhaler Therapy for Optimal Adherence: “No-Brainer” or Shared Decision?66
Table of Contents66
Could Corticosteroid/Antihistamine Combination Nasal Sprays Be Used as Anti-Inflammatory Reliever Therapy for Allergic Rhinitis?66
Respiratory Diseases Associated With Organic Dust Exposure64
SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?64
Information for Readers62
Gene Therapy for Inborn Errors of Immunity62
Macular Amyloidosis in an Atopic Patient After Aeroallergen Immunotherapy62
Managing CPAP Rhinitis60
Effects of Sex and Gender in Immediate β-Lactam Antibiotic Allergy: A Systematic Review and Meta-Analysis59
The Role of Patient Satisfaction Scores in Clinical Care and Physician Wellness58
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis57
Prevention of IgE-Mediated Food Allergy: Emerging Strategies Through Maternal and Neonatal Interventions56
FEF25-75% Is a More Sensitive Measure Reflecting Airway Dysfunction in Patients with Asthma: A Comparison Study Using FEF25-75% and FEV1%56
Another Therapy for Chronic Rhinosinusitis With Nasal Polyps55
Triggers for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy54
Risk Factors of Hypersensitivity Reactions to Carboplatin: A Systematic Review and Meta-Analysis54
Feeding difficulties in children with food protein–induced enterocolitis syndrome53
Table of Contents53
Effects of Pregnancy-Onset Asthma on Perinatal Outcomes: A Retrospective Cohort Study53
Persistent nivolumab-induced urticaria with vibratory and delayed-pressure angioedema51
Development of Food Allergy Data Dictionary: Toward a Food Allergy Data Commons51
Measuring Cough Severity: Time to Replace VAS With Patient Global Impression Scale?51
Impact of Ongoing Treatment With Inhaled Corticosteroids During Specific Inhalation Challenges for Diagnosing Occupational Asthma50
Asthma Management in Children49
Chronic norovirus infection in immunodeficiency: A UK national case series49
Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases49
Carboplatin risk stratification after a hypersensitivity reaction: Progress in our understanding of skin testing49
Allergic Rash Mimickers49
Indoor and Outdoor Fungal Allergens and Impacts on Respiratory Allergic Disease48
Sticking With It: The Continued Benefits of 2 Years of Peanut Epicutaneous Immunotherapy in Young Children48
Facilitated Subcutaneous Immunoglobulin 10% Safety Among Pediatric Patients With Primary Immunodeficiency Diseases48
0.055836915969849